Physician profile
Basil Skenderis
NPI 1164477469
$12,005.42
in general payments reported to CMS, 2019-2025
21 companies · $88.64 in 2025
The $88.64 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,939 · 2020: $48.65 · 2021: $35.25 · 2022: $282 · 2023: $175 · 2024: $3,436 · 2025: $88.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,410 · Consulting Fee: $1,250 · Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,410.47 |
| Consulting Fee | $1,250.00 |
| Food and Beverage | $1,039.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,921.55 | 2019-2020 | |
| Lifenet Health | $3,411.39 | 2023-2025 | Theragenesis Wound Matrix |
| Davol INC. | $604.33 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $449.22 | 2019 | |
| Bioventus LLC | $146.38 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $60.62 | 2022 | |
| Exact Sciences Corporation | $58.29 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $44.74 | 2023 | Sonicision |
| Abbvie INC. | $38.21 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.15 | 2022-2024 | |
| Lilly USA, LLC | $31.21 | 2025 | Kisunla, Zepbound, Mounjaro |
| Novo Nordisk INC | $30.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.64 | 2022-2024 | Xifaxan |
| Abbott Laboratories | $24.75 | 2024 | Proclaim |
| Kyowa Kirin, INC. | $22.39 | 2023 | Crysvita |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $21.58 | 2021 | |
| Avanos Medical | $17.82 | 2023 | On-Q* Pump and Accessories |
| Myriad Genetic Laboratories, INC. | $15.48 | 2022 | |
| Boston Scientific Corporation | $14.09 | 2023 | |
| Teleflex LLC | $13.67 | 2021 | |
| Covidien LP | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Skenderis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.